Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fresenius SE KGaAWBO:FRE +1.77%64 EV-to-OCF is 11.08 as of Jul. 17, 2026, which is 15% below its 10-year median of 12.97. GuruFocus rates WBO:FRE with a GF Score™ of 64/100 and a GF Value™ of €36.69 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 58.6% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Fresenius SE KGaA's Enterprise Value is €32,198 Mil.
Fresenius SE KGaA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €2,907 Mil. Therefore, Fresenius SE KGaA's EV-to-OCF for today is 11.08.
The historical rank and industry rank for Fresenius SE KGaA's EV-to-OCF or its related term are showing as below:
WBO:FRE'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.31 Med: 12.97 Max: 19.19
Current: 11.08
During the past 13 years, the highest EV-to-OCF of Fresenius SE KGaA was 19.19. The lowest was 6.31. And the median was 12.97.
WBO:FRE's EV-to-OCF is ranked worse than 58.6% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 8.695
vs WBO:FRE: 11.08
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fresenius SE KGaA's PE Ratio (TTM) for today is calculated as:
Fresenius SE KGaA's share price for today is €41.91.
Fresenius SE KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.600.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fresenius SE KGaA EV-to-OCF Related Terms
Fresenius SE KGaA EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Fresenius SE KGaA's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's EV-to-OCF falls into.
Fresenius SE KGaA's current Enterprise Value is €32,198 Mil.
Fresenius SE KGaA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,907 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (WBO:FRE) has a EV-to-OCF of 11.08 as of Jul. 17, 2026. This is 15% below median its historical median of 12.97. Over the past decade, Fresenius SE KGaA's EV-to-OCF has ranged from 6.31 to 19.19. According to the industry distribution chart, Fresenius SE KGaA ranks #402 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 58.6%.
Is Fresenius SE KGaA's EV-to-OCF too high?
Fresenius SE KGaA's current EV-to-OCF of 11.08 is 15% below median its 10-year median of 12.97. Over the past 10 years, this metric has ranged from a low of 6.31 to a high of 19.19. The Healthcare Providers & Services industry median EV-to-OCF is 8.70. Fresenius SE KGaA's value of 11.08 is 27.4% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #402 out of 686 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #402 out of 686 companies for EV-to-OCF. This places Fresenius SE KGaA in the lower half of its industry. The industry median EV-to-OCF is 8.70. Fresenius SE KGaA's value of 11.08 is 27.4% above this benchmark. Historically, Fresenius SE KGaA's own EV-to-OCF has ranged from 6.31 to 19.19 over the past decade. While the company's 10-year median is 12.97 vs. the industry median of 8.70, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.70, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current EV-to-OCF of 11.08 is 27.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current EV-to-OCF is 11.08, which is 15% below median its own 10-year median of 12.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (WBO:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is €36.69, compared to a current price of €41.91 — trading 14.2% above its estimated fair value. The current EV-to-OCF is 11.08, which is 15% below median its 10-year median of 12.97 and 27.4% above the Healthcare Providers & Services industry median of 8.70. Fresenius SE KGaA's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Fresenius SE KGaA (WBO:FRE), the current EV-to-OCF is 11.08 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (WBO:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of €41.91 is trading 14.2% above its estimated GF Value™ of €36.69.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for WBO:FRE:
EV-to-OCF: 11.08 (15% below median its 10-year median of 12.97)
GF Value™: €36.69 vs. price of €41.91 (14.2% above fair value)
Industry Position: 27.4% above the Healthcare Providers & Services median (#402 of 686)
No single metric tells the full story. See the WBO:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
64GF Score
Get the complete analysis for WBO:FRE
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:FRE has been successfully added to your 
